Full-Time

Senior Manager – Global Labeling Lead

Confirmed live in the last 24 hours

Pfizer

Pfizer

10,001+ employees

Develops and manufactures vaccines and medicines

Biotechnology
Healthcare

Compensation Overview

$117.3k - $195.5kAnnually

+ Bonus

Senior

No H1B Sponsorship

Bothell, WA, USA + 2 more

More locations: San Bruno, CA, USA | La Jolla, San Diego, CA, USA

Hybrid role requiring average 3 days onsite; must be within 50 miles of a Pfizer site (WA-Seattle, CA-SFO, CA-San Diego).

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Bachelor’s degree in a scientific or technical discipline.
  • Minimum of 8 years of relevant labeling experience in the pharmaceutical or biotech industry.
  • Advanced knowledge of external labeling guidelines and regulations.
  • Ability to successfully understand regulatory implications of product strategy with regards to the product label, assessment and practical management of associated impacts.
Responsibilities
  • Lead the development, maintenance, and implementation of high quality labeling including CDS, USPIs, EU SmPCs, and patient labeling
  • Author labeling content de novo based on scientific source data, understanding of regulations and guidance, and label precedent
  • Manage cross-functional Labeling Team and collaborate with stakeholders including Clinical, Medical, Safety, Regulatory, and Commercial
  • Drive global labeling strategy through development of target labeling, scenario planning, and risk mitigation
  • Manage label negotiations with US FDA and EMA
  • Provide guidance on labeling regulations, industry best practices, and competitor label assessments
  • Act as the primary labeling representative on Global Regulatory Strategy Teams, Submission Working Groups, and other relevant product teams
  • Contribute to strategic initiatives and process improvements across the organization

Pfizer is a biopharmaceutical company that focuses on creating and producing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold to various clients such as governments, healthcare providers, and patients around the world. Pfizer's products include vaccines, oncology treatments, and other specialized medicines. A notable achievement is its partnership with BioNTech to develop a vaccine for COVID-19, which has played a significant role in addressing the pandemic. Pfizer aims to improve public health by ensuring access to vaccines, especially for underserved populations, and continues to grow its product offerings with new approvals and treatments.

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Pfizer's significant investments in companies like CellCentric and Caribou Biosciences indicate a strong focus on expanding its oncology and cell therapy capabilities.
  • The company's proactive approach in securing investments and partnerships positions it well for future growth and innovation in the biopharmaceutical sector.
  • Pfizer's involvement in funding rounds for promising biotech firms suggests potential for lucrative returns and strategic advancements in healthcare solutions.

What critics are saying

  • The slowdown in demand for COVID-19 vaccines could impact Pfizer's revenue and market perception.
  • Activist investor involvement, such as Starboard Value's $1 billion stake, may lead to pressure for strategic changes that could affect company stability.

What makes Pfizer unique

  • Pfizer's strategic partnerships and investments in innovative biotech companies like Promise Bio and Enara Bio highlight its commitment to cutting-edge research and development.
  • The company's collaboration with BioNTech for the COVID-19 vaccine showcases its ability to rapidly respond to global health crises, setting it apart from many competitors.
  • Pfizer's diverse portfolio, including oncology and specialized medicines, ensures a broad market reach beyond just vaccines.

Help us improve and share your feedback! Did you find this helpful?